College of Pharmacy News

An independent advisory committee to the FDA has determined that phenylephrine, a popular ingredient in many over-the-counter allergy and cold medicines, is ineffective in tablet form. CNN and numerous other national news outlets quote from the College of Pharmacy's Associate Dean for Healthcare Partnerships Dr. Diane Ginsburg, who serves on the committee, regarding this decision.

The University of Texas Health Science Center at San Antonio (also called UT Health San Antonio) and seven regional partners and collaborators, including The University of Texas at Austin College of Pharmacy, will leverage $46 million from the National Institutes of Health (NIH) over the next five to seven years to translate scientific discoveries into therapeutic benefits for human health and well-being.

Kimberly J. Long, a Ph.D. candidate in the Dalby Lab in the Division of Chemical Biology and Medicinal Chemistry, was a first author of a recent research paper published in the Proceedings of the National Academy of Sciences (PNAS).

The University of Texas at Austin College of Pharmacy earns accolades for Best in Community Engagement, Best in Health Innovation, Best Project in Progress, Best in Visual and top 3 for People’s Choice Award at the Interprofessional Health Showcase 2023.

Clinical Assistant Professor of Pharmacy Practice K. Ashley Garling-Nañez, Pharm.D. talked to the Washington Post's Andrea Sachs about what to expect from pharmacies when traveling abroad.

The Cancer Prevention and Research Institute of Texas granted UT’s Lee Lab $1 million to strengthen skin cancer research last month following breakthroughs in understanding how melanoma develops.

Two of the college's distinguished faculty in the Division of Health Outcomes and Division of Pharmacy Practice were recommended for promotion by President Hartzell due to their outstanding accomplishments in research, outreach and education. Dr. Tish Moczygemba will assume the rank of professor and Dr. Kristin Janzen will become a clinical associate professor.

Clinical Associate Professor in the Division of Pharmacotherapy Dr. Kirk Evoy spoke to CNN about the possibilities of making naloxone, a medication used to reverse or reduce the effects of opioids, available over-the-counter.

Texas Pharmacy is delighted to announce its new Assistant Dean for Diversity and Inclusion Tonia Guida, Ph.D.

The Cancer Prevention and Research Institute of Texas (CPRIT) has released its grant research funding awards for the upcoming year. All three awarded research projects at The University of Texas at Austin involve College of Pharmacy faculty.